Home » Cardium Completes Patient Evaluations for Phase IIb Clinical Study
Cardium Completes Patient Evaluations for Phase IIb Clinical Study
Cardium Therapeutics announced that all patients enrolled in the Company’s Matrix clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May